title: Prevalence of upper gastrointestinal mucosal abnormalities at a rheumatology clinic.
authors.forename: J
authors.initials: J
authors.lastname: Senior
authors.forename: C
authors.initials: C
authors.lastname: Rubio
authors.forename: E
authors.initials: E
authors.lastname: González Pares
authors.forename: E A
authors.initials: EA
authors.lastname: Torres
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D004382:Duodenitis / Q000139:chemically induced* / Q000453:epidemiology; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects* / Q000473:pathology; D005756:Gastritis / Q000139:chemically induced* / Q000453:epidemiology; D005773:Gastroscopy; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000150:complications* / Q000188:drug therapy; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000453:epidemiology; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects*; D011647:Puerto Rico
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011241:Prednisone